Neutrophils display potent bactericidal activity toward Actinobacillus actinomycetemcomitans (A.a.), but only in the presence of specific IgG antibody. Localized juvenile periodontitis (LJP) subjects produce substantial amounts of IgG2 antibody against this organism. The ability of IgG2 to support phagocytosis of A.a. may be limited by the capacity of phagocyte IgG Fc receptors to bind this subclass. FcgRII, the main IgG Fc receptor present on neutrophils, exhibits a genetically-defined structural polymorphism which significantly affects IgG2 binding. One allotype, which contains histidine (H) at position 131, binds IgG2 efficiently, whereas the allotype containing arginine (R) at this position does not. In the present study, working with Dr. Mark Wilson, we determined FcgRIIA allotype in two families with LJP. FcgRILA was amplified from genomic DNA by PCR, after which FcgRIIA genotype was determined using an allele-specific oligonucleotide probe assay. Severity of periodontal disease was determined by radiographic loss of alveolar bone and by probing depth. The three most severe cases of LJP exhibited the R/R genotype, as did two post-LJP patients. The other two LJP patients, presenting with a less severe form of the disease, demonstrated H/R genotypes. The remaining subject, who did not exhibit LJP, was H/R. These preliminary results suggest that increased risk for development of LJP may be due to a unique combination of production of substantial amounts of IgG2 antibodies against A .a. and a decreased frequency of expression of the H allele of FcgRIIA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Unknown (K16)
Project #
2K16DE000158-11
Application #
5208669
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1996
Total Cost
Indirect Cost
Krebs, Linda J; Wang, Xiaopeng; Nagy, Atilla et al. (2002) Bombesin and epidermal growth factor potentiate the effect of cytotoxic LH-RH analog AN-152 in vitro. Int J Oncol 21:1325-9
Krebs, Linda J; Wang, Xiaopeng; Nagy, Attila et al. (2002) A conjugate of doxorubicin and an analog of Luteinizing Hormone-Releasing Hormone shows increased efficacy against oral and laryngeal cancers. Oral Oncol 38:657-663
Rogers, J D; Scannapieco, F A (2001) RegG, a CcpA homolog, participates in regulation of amylase-binding protein A gene (abpA) expression in Streptococcus gordonii. J Bacteriol 183:3521-5
Krebs, L J; Wang, X; Pudavar, H E et al. (2000) Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor. Cancer Res 60:4194-9
Malek, R; Fisher, J G; Caleca, A et al. (1994) Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J Bacteriol 176:1052-9
Dolce, C; Anguita, J; Brinkley, L et al. (1994) Effects of sialoadenectomy and exogenous EGF on molar drift and orthodontic tooth movement in rats. Am J Physiol 266:E731-8
Stephan, E B; Dziak, R (1994) Effects of genistein, tyrphostin, and pertussis toxin on EGF-induced mitogenesis in primary culture and clonal osteoblastic cells. Calcif Tissue Int 54:409-13
Grossi, S G; Zambon, J J; Ho, A W et al. (1994) Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 65:260-7
Winston, J L; Chen, C K; Neiders, M E et al. (1993) Membrane protein expression by Actinobacillus actinomycetemcomitans in response to iron availability. J Dent Res 72:1366-73
Sharma, A; Sojar, H T; Lee, J Y et al. (1993) Expression of a functional Porphyromonas gingivalis fimbrillin polypeptide in Escherichia coli: purification, physicochemical and immunochemical characterization, and binding characteristics. Infect Immun 61:3570-3

Showing the most recent 10 out of 24 publications